
Popular artificial sweetener may negatively affect cancer immunotherapy
Non-sugar, or artificial, sweeteners are widely used to reduce the energy in sweetened foods and drinks, particularly those marketed as diet, or low or no sugar. However, concerns about their possible health effects include links to gastrointestinal problems, metabolic effects, and even increased cancer risk. Now, a study has found that one of the most widely used artificial sweeteners, sucralose, could adversely affect cancer immunotherapy. The researchers suggest that by changing the gut microbiome, sucralose decreases the effectiveness of immunotherapy for several cancers.